
Good morning, Broadsheet readers! The National Portrait Gallery unveils an Oprah portrait, South Korean internet giant Kakao taps Shina Chung as CEO, and business should pay attention to SCOTUS's next major abortion case. Have a thoughtful Thursday!
- One to watch. In early 2023, the post-Roe political fight over abortion rights expanded to mifepristone, one of two drugs used in medication abortion. Mifepristone, used in half of all pregnancy terminations in the U.S., was allowed to stay on the market as these legal challenges progressed.